Market Cap 234.65M
Revenue (ttm) 26.39M
Net Income (ttm) -62.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -235.05%
Debt to Equity Ratio 0.00
Volume 487,500
Avg Vol 525,408
Day's Range N/A - N/A
Shares Out 143.96M
Stochastic %K 79%
Beta 0.15
Analysts Strong Sell
Price Target $7.86

Company Profile

OmniAb, Inc., a biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada. The company's technology platform creates and screens diverse antibody repertoires to identify optimal antibodies and other target-binding proteins for partners' drug development efforts. Its OmniAb platform's Biological Intelligence powers the immune systems...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 250 7800
Address:
5980 Horton Street, Suite 600, EmeryVille, United States
AIAdept
AIAdept Oct. 5 at 3:12 PM
$OABI SPAC structure. Pre-merger speculation. Trading near trust value. Redemption risk present.
1 · Reply
a36er
a36er Sep. 29 at 7:54 PM
$OABI At 3:44pm a block of 1.4M traded.
1 · Reply
bearsoil
bearsoil Sep. 25 at 11:35 PM
$OABI OABI Business model is different than most biotechs. That’s why it’s having a hard time gaining traction. It depends on its customers success more than developing its own drugs through trials. Wall Street has a hard time valuing a biotech license company. Especially an early stage company like AOBI. Right now investors are just looking at the cash burn rate. They have big name customers but with confidential agreements set up we dont see many press releases about specific deals. You have to wait for each quarter CC to get any color of progress. All that being said makes it challenging to get any significant volume for a penny stock However their science is unique and eventually customer growth will show up. Reminds me of another LGND spinoff VKTX when you couldn’t give it away at1.25 This low price on OABI won’t last forever
1 · Reply
bearsoil
bearsoil Sep. 19 at 8:22 PM
$OABI Large trades in last few minutes Once insttutions realize some of the big name companies that OABI has as customers stock should treade up from this low price
1 · Reply
PlannedTrading101
PlannedTrading101 Sep. 17 at 7:50 PM
$OABI Still here accumulating. I am positive this will have a nice run from these levels.
0 · Reply
bearsoil
bearsoil Sep. 15 at 9:38 PM
$OABI Large trading volume during the last hour. Interesting science. Great potential. But boy do they spend a lot on R and D. Different than clinical trials as far as time frames but expensive testing. Once some daylight on significant revenues are seen this stock should move up.
0 · Reply
DARKP00L
DARKP00L Sep. 12 at 8:15 PM
$OABI 16:05 on Sep. 12 2025 OmniAb Files For Offering Of 21.3M Shares By Selling Stockholders #tradeideas
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 7:28 AM
$OABI Great piece that accurately captures OABI's current position. So if you want to refresh your understanding of OABI or learn about OABI for the first time, this is essential reading. https://beyondspx.com/quote/OABI/analysis/omniab-unlocking-antibody-discovery-through-biological-intelligence-and-strategic-innovation-nasdaq-oabi
1 · Reply
DARKP00L
DARKP00L Sep. 4 at 2:10 PM
$OABI this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
tranq19
tranq19 Aug. 26 at 8:13 PM
$OABI at least Foehr picked up another 500k shares in the offering at 1.85
1 · Reply
Latest News on OABI
OmniAb Announces $30 Million Private Placement

Aug 25, 2025, 7:00 AM EDT - 6 weeks ago

OmniAb Announces $30 Million Private Placement


OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 2:24 AM EDT - 2 months ago

OmniAb, Inc. (OABI) Q2 2025 Earnings Call Transcript


OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:52 AM EDT - 5 months ago

OmniAb, Inc. (OABI) Q1 2025 Earnings Call Transcript


OmniAb Introduces the xPloration® Partner Access Program

May 8, 2025, 4:05 PM EDT - 5 months ago

OmniAb Introduces the xPloration® Partner Access Program


OmniAb to Participate in Five Upcoming Investor Conferences

May 1, 2025, 8:00 AM EDT - 5 months ago

OmniAb to Participate in Five Upcoming Investor Conferences


OmniAb Announces Two New Appointments to its Board of Directors

Apr 21, 2025, 8:00 AM EDT - 6 months ago

OmniAb Announces Two New Appointments to its Board of Directors


OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 7 months ago

OmniAb, Inc. (OABI) Q4 2024 Earnings Call Transcript


OmniAb to Participate in Two Investor Conferences in March

Feb 3, 2025, 4:57 PM EST - 8 months ago

OmniAb to Participate in Two Investor Conferences in March


Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm

Jan 31, 2025, 11:09 AM EST - 8 months ago

Kuehn Law Encourages Investors of OmniAb, Inc. to Contact Law Firm


OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 9:53 PM EST - 11 months ago

OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript


OmniAb to Participate in Two Investor Conferences in November

Oct 30, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Two Investor Conferences in November


OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 11:28 AM EDT - 1 year ago

OmniAb, Inc. (OABI) Q2 2024 Earnings Call Transcript


OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript

May 10, 2024, 4:33 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q1 2024 Earnings Call Transcript


OmniAb to Participate in Five Investor Conferences in May

May 1, 2024, 8:00 AM EDT - 1 year ago

OmniAb to Participate in Five Investor Conferences in May


OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript

Mar 20, 2024, 7:38 PM EDT - 1 year ago

OmniAb, Inc. (OABI) Q4 2023 Earnings Call Transcript


OmniAb Appoints Steve Love to its Board of Directors

Nov 1, 2023, 9:00 AM EDT - 2 years ago

OmniAb Appoints Steve Love to its Board of Directors


OmniAb: Hold For Growth

Sep 25, 2023, 9:22 PM EDT - 2 years ago

OmniAb: Hold For Growth


OmniAb, Inc. (OABI) Q2 2023 Earnings Call Transcript

Aug 12, 2023, 2:39 PM EDT - 2 years ago

OmniAb, Inc. (OABI) Q2 2023 Earnings Call Transcript


OmniAb Announces the Passing of Director Sunil Patel

Aug 7, 2023, 4:05 PM EDT - 2 years ago

OmniAb Announces the Passing of Director Sunil Patel


AIAdept
AIAdept Oct. 5 at 3:12 PM
$OABI SPAC structure. Pre-merger speculation. Trading near trust value. Redemption risk present.
1 · Reply
a36er
a36er Sep. 29 at 7:54 PM
$OABI At 3:44pm a block of 1.4M traded.
1 · Reply
bearsoil
bearsoil Sep. 25 at 11:35 PM
$OABI OABI Business model is different than most biotechs. That’s why it’s having a hard time gaining traction. It depends on its customers success more than developing its own drugs through trials. Wall Street has a hard time valuing a biotech license company. Especially an early stage company like AOBI. Right now investors are just looking at the cash burn rate. They have big name customers but with confidential agreements set up we dont see many press releases about specific deals. You have to wait for each quarter CC to get any color of progress. All that being said makes it challenging to get any significant volume for a penny stock However their science is unique and eventually customer growth will show up. Reminds me of another LGND spinoff VKTX when you couldn’t give it away at1.25 This low price on OABI won’t last forever
1 · Reply
bearsoil
bearsoil Sep. 19 at 8:22 PM
$OABI Large trades in last few minutes Once insttutions realize some of the big name companies that OABI has as customers stock should treade up from this low price
1 · Reply
PlannedTrading101
PlannedTrading101 Sep. 17 at 7:50 PM
$OABI Still here accumulating. I am positive this will have a nice run from these levels.
0 · Reply
bearsoil
bearsoil Sep. 15 at 9:38 PM
$OABI Large trading volume during the last hour. Interesting science. Great potential. But boy do they spend a lot on R and D. Different than clinical trials as far as time frames but expensive testing. Once some daylight on significant revenues are seen this stock should move up.
0 · Reply
DARKP00L
DARKP00L Sep. 12 at 8:15 PM
$OABI 16:05 on Sep. 12 2025 OmniAb Files For Offering Of 21.3M Shares By Selling Stockholders #tradeideas
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 7:28 AM
$OABI Great piece that accurately captures OABI's current position. So if you want to refresh your understanding of OABI or learn about OABI for the first time, this is essential reading. https://beyondspx.com/quote/OABI/analysis/omniab-unlocking-antibody-discovery-through-biological-intelligence-and-strategic-innovation-nasdaq-oabi
1 · Reply
DARKP00L
DARKP00L Sep. 4 at 2:10 PM
$OABI this stock is attracting a lot of interest. Be prepared for possible changes!
0 · Reply
tranq19
tranq19 Aug. 26 at 8:13 PM
$OABI at least Foehr picked up another 500k shares in the offering at 1.85
1 · Reply
The300
The300 Aug. 26 at 11:48 AM
$OABI business drying up as the main platform (omniab rats) has become a commodity. management diluting shareholders and flaying around for new sources of revenue while they wait (years!) for royalties to kick in. The obvious move would be to shut down operations, send cash back to shareholder, and hibernate until royalties mature…. but they won’t…
0 · Reply
OpenOutcrier
OpenOutcrier Aug. 25 at 12:50 PM
$OABI (-9.2% pre) OmniAb raises $30 million in private placement at $1.40 per share https://ooc.bz/l/75062
2 · Reply
DonCorleone77
DonCorleone77 Aug. 25 at 11:16 AM
$OABI OmniAb to sell 21.254M shares at $1.40 in private placement
0 · Reply
PlannedTrading101
PlannedTrading101 Aug. 22 at 5:48 PM
$OABI Still accumulating here. Chart looks solid. Just needs some volume or positive news and this goes fast IMO.
0 · Reply
bearsoil
bearsoil Aug. 20 at 7:45 PM
$OABI Selloff on low volume Price point at 1.85 looking attractive
0 · Reply
PlannedTrading101
PlannedTrading101 Aug. 13 at 2:24 PM
$OABI Ready to breakout!! Cmon lets go!
0 · Reply
PlannedTrading101
PlannedTrading101 Aug. 8 at 3:19 PM
$OABI Still accumulating under 2.00. This will be a nice winner IMO. Price targets from $4-$11
0 · Reply
JarvisFlow
JarvisFlow Aug. 7 at 3:12 PM
RBC Capital has adjusted their stance on OmniAb ( $OABI ), setting the rating to Outperform with a target price of 4 → 3.
0 · Reply
MadDogs
MadDogs Aug. 7 at 1:42 PM
$OABI I’ll be averaging down lol 🤠
0 · Reply
MadDogs
MadDogs Aug. 6 at 6:26 AM
$TEM and $OABI 🤠
0 · Reply
MadDogs
MadDogs Aug. 5 at 6:29 PM
$OABI added 🤠
0 · Reply
PlannedTrading101
PlannedTrading101 Aug. 5 at 6:08 PM
$OABI 2.22 break could trigger some buying!
0 · Reply